241 related articles for article (PubMed ID: 24307571)
1. Dynamic contrast-enhanced MRI to evaluate the therapeutic response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Kim SH; Lee JM; Gupta SN; Han JK; Choi BI
J Magn Reson Imaging; 2014 Sep; 40(3):730-7. PubMed ID: 24307571
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI: Use in predicting pathological complete response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Tong T; Sun Y; Gollub MJ; Peng W; Cai S; Zhang Z; Gu Y
J Magn Reson Imaging; 2015 Sep; 42(3):673-80. PubMed ID: 25652254
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast enhanced MR imaging for rectal cancer response assessment after neo-adjuvant chemoradiation.
Intven M; Reerink O; Philippens ME
J Magn Reson Imaging; 2015 Jun; 41(6):1646-53. PubMed ID: 25124320
[TBL] [Abstract][Full Text] [Related]
5. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
7. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
Zou HH; Yu J; Wei Y; Wu JF; Xu Q
J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
[TBL] [Abstract][Full Text] [Related]
8. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
9. Diffusion-weighted imaging for evaluating lymph node eradication after neoadjuvant chemoradiation therapy in locally advanced rectal cancer.
Ryu KH; Kim SH; Yoon JH; Lee Y; Paik JH; Lim YJ; Lee KH
Acta Radiol; 2016 Feb; 57(2):133-41. PubMed ID: 25638800
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
11. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy.
Kim SH; Lee JM; Hong SH; Kim GH; Lee JY; Han JK; Choi BI
Radiology; 2009 Oct; 253(1):116-25. PubMed ID: 19789256
[TBL] [Abstract][Full Text] [Related]
12. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
[TBL] [Abstract][Full Text] [Related]
13. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
14. Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer.
Lim JS; Kim D; Baek SE; Myoung S; Choi J; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW; Keum KC
Eur Radiol; 2012 Aug; 22(8):1693-700. PubMed ID: 22427184
[TBL] [Abstract][Full Text] [Related]
15. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
[TBL] [Abstract][Full Text] [Related]
16. [Value of diffusion-weighted magnetic resonance imaging in prediction of the response to preoperative chemoradiotherapy in rectal carcinoma].
Liang X; Zhang HM; Ye F; Ouyang H; Zhao XM; Zhou CW
Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):133-7. PubMed ID: 26899334
[TBL] [Abstract][Full Text] [Related]
17. Locally advanced rectal cancer: post-chemoradiotherapy ADC histogram analysis for predicting a complete response.
Cho SH; Kim GC; Jang YJ; Ryeom H; Kim HJ; Shin KM; Park JS; Choi GS; Kim SH
Acta Radiol; 2015 Sep; 56(9):1042-50. PubMed ID: 25270374
[TBL] [Abstract][Full Text] [Related]
18. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract][Full Text] [Related]
19. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging.
Sun YS; Zhang XP; Tang L; Ji JF; Gu J; Cai Y; Zhang XY
Radiology; 2010 Jan; 254(1):170-8. PubMed ID: 20019139
[TBL] [Abstract][Full Text] [Related]
20. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters?
Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH
Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
